Hemostemix Inc (TSX:HEM)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - HEM

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - HEM

  • Market CapCAD15.810m
  • SymbolTSX:HEM
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINCA4236943060

Company Profile

Hemostemix Inc is a clinical-stage biotechnology company. Its principal business activity is to develop, manufacture, and commercialize blood-derived cell therapies for medical conditions. The company's technology platform for developing autologous cell therapies is for the treatment of vascular diseases. The group's clinical-stage candidate, ACP-01, is an autologous cell therapy for the treatment of critical limb ischemia.Hemostemix Inc is a Canada based clinical-stage biotechnology company. Its principal business activity is to develop, manufacture and commercialize blood-derived cell therapies for medical conditions.

Latest HEM news

Currently there for this company. Visit our news hub for other news .